SCIENTIFIC HUB

Follow the evidence.

106.818 articles found

Source record

Serum HDL-cholesterol is associated with the clinical-biological profile of early-stage Parkinson's disease patients independently of APOE.

Mascioli D, Conti M, Bissacco J, Bovenzi R, Simonetta C, Buttarazzi V, Mancini M, Bagetta S, Sancesario GM, Maftei D, Veltri F, Marchionni E, Stefani A, Mercuri NB, Pieri M, Schirinzi T.

Neurobiol Aging · 2025-07-05

DOI: 10.1016/j.neurobiolaging.2025.07.004PMID: 40633495

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Mesenchymal stem cell membrane camouflaged mesoporous polydopamine for Parkinson's disease treatment via alleviating oxidative stress mediated neuroinflammation.

Chen Y, Lv W, Xu J, Li S, Song K, Gong Y, Zhao W, Liu H, Ding Z, Liu L, Yin J, Su D, Lu M, Fang X, Xin H.

Biomaterials · 2025-07-05

DOI: 10.1016/j.biomaterials.2025.123537PMID: 40627962

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Distinctive cognitive phenotypes in Parkinson's disease patients with GBA mutations and without dementia: a multicentre cross-sectional retrospective study.

Longo C, Liccari M, Bacchin R, Papagno C, Ottaviani D, Giacopo RD, Catalan M, Menichelli A, Marano M, Fonzo AD, Duro G, Zizzo C, Manganotti P, Giometto B, Malaguti MC.

Clin Park Relat Disord · 2025-07-04

DOI: 10.1016/j.prdoa.2025.100365PMID: 40687116

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.